Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients
- PMID: 11856484
- PMCID: PMC5926951
- DOI: 10.1111/j.1349-7006.2002.tb01259.x
Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients
Abstract
Serine proteinase inhibitor 9 (PI-9) inhibits granzyme B-mediated apoptosis and interleukin-1beta-converting enzyme activity. In this study, we report that the PI-9 gene encodes antigenic epitopes recognized by the HLA-A24-restricted and tumor-reactive cytotoxic T lymphocytes (CTLs) of epithelial cancer patients. Screening of an autologous cDNA library using a CTL line recognizing HLA-A24+ tumor cells resulted in the isolation of a cDNA, which had an identical coding region to the previously described PI-9 genes. PI-9 gene was expressed in approximately three-fourths of epithelial cancer cell lines and all leukemic cell lines tested. It was also expressed in normal peripheral blood mononuclear cells (PBMCs), but not in a normal fibroblast cell line. CTL sublines contained T cells capable of recognizing the PI-9(292-300) and PI-9(348-356) peptides among 13 different peptides having the HLA-A24 binding motifs. These two peptides were recognized by the CTL line in a dose-dependent and HLA class-I-restricted manner, and also possessed the ability to induce HLA class I-restricted and tumor-reactive CTLs in PBMCs from HLA-A24+ cancer patients. These results demonstrate that PI-9 is recognized by HLA class I-restricted and tumor-reactive CTLs of epithelial cancer patients.
References
-
- van der Bruggen , P. , Traversari , C. , Chomez , P. , Lurqin , C. , Plaen , E. D. , van der Eynde , B. , Knuth , A. and Boon , T.A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma . Science , 254 , 1643 – 1647 ( 1991. ). - PubMed
-
- Kawakami , Y. , Eliyahu , S. , Sakaguchi , K. , Robbins , P. F. , Rivoltini , L. , Yannelli , J. B. , Appella , E. and Rosenberg , S. A.Identification of the immunodominant peptides of the MART–1 human melanoma antigen recognized by the majority of HLA‐A2 restricted tumor infiltrating lymphocytes . J. Exp. Med. , 180 , 347 – 352 ( 1994. ). - PMC - PubMed
-
- Kawakami , Y. , Eliyahu , S. , Delgado , C. H. , Robbins , P. F. , Sakaguchi , K. , Appella , E. and Rosenberg , S. A.Identification of a human melanoma antigen recognized by tumor‐ infiltrating lymphocytes associated with in vivo tumor rejection . Proc. Natl. Acad. Set. USA , 91 , 6465 – 6462 ( 1994. ). - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous